Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | FAAH | O00519 | 3/20 | 0.44 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TERT | O14746 | 2/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9305406 | 1.00 | MAPT (0.59) | MAPTABCC4ALDH1A1LMNATSHR | |
| SCHEMBL9304385 | 1.00 | MAPT (0.59) | MAPTABCC4ALDH1A1LMNATSHR | |
| SCHEMBL514190 | 1.00 | MAPT (0.59) | MAPTABCC4ALDH1A1LMNATSHR | |
| SCHEMBL8408162 | 1.00 | MAPT (0.59) | MAPTABCC4ALDH1A1LMNATSHR | |
| SCHEMBL3120677 | 1.00 | MAPT (0.59) | MAPTABCC4ALDH1A1LMNATSHR | |
| SCHEMBL11859532 | 0.98 | MAPT (0.57) | MAPTABCC4ALDH1A1LMNATSHR | |
| SCHEMBL515388 | 0.98 | MAPT (0.56) | MAPTABCC4ALDH1A1LMNATSHR | |
| Methylamine SCHEMBL27712930 | 0.96 | MAPT (0.55) | MAPTABCC4ALDH1A1LMNATSHR | |
| Hydrochloric Acid SCHEMBL27448355 | 0.92 | MAPT (0.50) | MAPTABCC4ALDH1A1LMNATSHR | |
| SCHEMBL514517 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3856709-B1 | SYNTHESIS OF CYCLOPENTENONES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-06-26 | — | — | EP | claimed |
| CN-112601731-B | Synthesis of cyclopentenone | 陶氏环球技术有限责任公司 | 2023-10-03 | — | — | CN | claimed |
| US-11292757-B2 | Synthesis of cyclopentenones | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-04-05 | — | — | US | claimed |
| EP-3856752-B1 | SYNTHESIS OF SUBSTITUTED CYCLOPENTADIENE COMPOUNDS AND METALLOCENES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12570787-B2 | Curable compositions and articles prepared therefrom | TRANSITIONS OPTICAL, LTD. (IE) | 2026-03-10 | — | — | US | disclosed |
| US-12503543-B2 | Curable photochromic polycarbodiimide compositions | TRANSITIONS OPTICAL, LTD. (IE) | 2025-12-23 | — | — | US | disclosed |
| US-12247168-B2 | Curable photochromic compositions including an oxazoline functional material | TRANSITIONS OPTICAL, LTD. (IE) | 2025-03-11 | — | — | US | disclosed |
| CN-114901717-B | Curable photochromic polymers carbodiimide composition | 光学转变有限公司 | 2024-10-29 | — | — | CN | disclosed |
| EP-3856709-B1 | SYNTHESIS OF CYCLOPENTENONES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20230323011-A1 | Curable Compositions and Articles Prepared Therefrom | TRANSITIONS OPTICAL, LTD. (IE) | 2023-10-12 | — | — | US | disclosed |
| CN-112601731-B | Synthesis of cyclopentenone | 陶氏环球技术有限责任公司 | 2023-10-03 | — | — | CN | disclosed |
| US-20120029229-A1 | METHOD FOR PRODUCING HIGH PURITY TERMINAL OLEFIN COMPOUND | KURARAY CO., LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
| US-7714087-B2 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2010-05-11 | — | — | US | disclosed |
| EP-1734061-B1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer and uses thereof | MITSUI CHEMICALS INC (JP) | 2010-04-07 | — | — | EP | disclosed |
| US-20090137757-A1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | IMUTA JUNICHI | 2009-05-28 | — | — | US | disclosed |
| US-7393907-B2 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2008-07-01 | — | — | US | disclosed |
| EP-1734061-A2 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2006-12-20 | — | — | EP | disclosed |
| US-20040122192-A1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. | 2004-06-24 | — | — | US | disclosed |
| US-20020156207-A1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2002-10-24 | — | — | US | disclosed |
| EP-1186619-A2 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition contaning the copolymer, and uses thereof | Mitsui Chemicals, Inc. (JP) | 2002-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570787-B2 | Curable compositions and articles prepared therefrom | EHMT2, EHMT1, BHMT2 | MAPT 365/4885ABCC4 4140/4885ALDH1A1 1039/4885 |
| US-20120029229-A1 | METHOD FOR PRODUCING HIGH PURITY TERMINAL OLEFIN COMPOUND | ADH1A, ADH1C, OSBP | MAPT 1768/4885ABCC4 4712/4885ALDH1A1 233/4885 |
| US-11292757-B2 | Synthesis of cyclopentenones | FDPS, COASY, DHPS | MAPT 3533/4885ABCC4 2032/4885ALDH1A1 2774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.